News for Sanofi Stock (SNY)

Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial

CNBC • 04/04/24

Diabetes medication appears to slow progress of Parkinson's disease in French-backed trial

Market Watch • 04/04/24

Sanofi to Settle Claims That Heartburn Drug Zantac Caused Cancer

WSJ • 04/03/24

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

Reuters • 04/03/24

Sanofi: My Top Pick In Big Pharma

Seeking Alpha • 03/25/24

Press Release: Availability of the Q1 2024 Memorandum for modelling purposes

GlobeNewsWire • 03/22/24

Kymera Therapeutics: Advancing Into Phase 2 With Partner Sanofi - I Still Have Faith

Seeking Alpha • 03/21/24

Passport to Profits: 7 Global Growth Gems to Diversify Your Holdings

InvestorPlace • 03/13/24

Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript)

Seeking Alpha • 03/13/24

Sanofi (SNY) Leerink Partners Global Biopharma Conference (Transcript)

Seeking Alpha • 03/12/24

Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis

GlobeNewsWire • 03/11/24

Astra-Sanofi's RSV therapy 'highly effective' against infant hospitalizations, CDC study shows

Reuters • 03/07/24

Sanofi (SNY) TD Cowen 44th Annual Health Care Conference (Transcript)

Seeking Alpha • 03/04/24

‘GRANOLAS' vs. the Magnificent Seven: Which should you dig into now?

Market Watch • 02/29/24

3 Cash Cow Dividend Stocks for Outsized Income & Upside

InvestorPlace • 02/27/24

Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria

GlobeNewsWire • 02/24/24

Press Release: Filing of the 2023 U.S. Form 20-F and French “Document d'Enregistrement Universel” containing the Annual Financial Report

GlobeNewsWire • 02/23/24

Press Release: Dupixent® sBLA accepted for FDA Priority Review for treatment of COPD with type 2 inflammation

GlobeNewsWire • 02/23/24

Press Release: Sanofi's Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors

GlobeNewsWire • 02/22/24

Move Over Magnificent 7, Say Hello to the GRANOLAS

InvestorPlace • 02/22/24

Sanofi's consumer healthcare spin-off attracts private equity interest, sources say

Reuters • 02/20/24

Blackstone may soon buy Sanofi's consumer health unit

Invezz • 02/20/24

Denali-Sanofi's ALS drug fails to meet main goal of mid-stage trial

Reuters • 02/16/24

2 Healthcare Stocks You Can Buy and Hold for the Next Decade

The Motley Fool • 02/16/24

Press Release: Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)

GlobeNewsWire • 02/16/24